| P50 | author | Shyh-han Tan | Q43195755 |
| | Gyorgy Petrovics | Q82992945 |
| P2093 | author name string | Shiv Srivastava | |
| | Albert Dobi | |
| | Ahmed A Mohamed | |
| | Shilpa Katta | |
| | Francisco Saenz | |
| | Rajesh Thangapazham | |
| P2860 | cites work | ETS transcription factors control transcription of EZH2 and epigenetic silencing of the tumor suppressor gene Nkx3.1 in prostate cancer | Q21091136 |
| | The erg gene: a human gene related to the ets oncogene | Q24299030 |
| | NKX3.1 activates cellular response to DNA damage | Q24306760 |
| | Loss of Nkx3.1 leads to the activation of discrete downstream target genes during prostate tumorigenesis | Q24314483 |
| | Cloning of the TMPRSS2 gene, which encodes a novel serine protease with transmembrane, LDLRA, and SRCR domains and maps to 21q22.3 | Q24316419 |
| | Inflammatory cytokines induce phosphorylation and ubiquitination of prostate suppressor protein NKX3.1 | Q24337092 |
| | A FOXA1-binding enhancer regulates Hoxb13 expression in the prostate gland | Q24646455 |
| | The mutational landscape of prostate cancer | Q26851631 |
| | Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. | Q27824849 |
| | erg, a human ets-related gene on chromosome 21: alternative splicing, polyadenylation, and translation | Q28295357 |
| | MatInspector and beyond: promoter analysis based on transcription factor binding sites | Q29616314 |
| | Frequent overexpression of ETS-related gene-1 (ERG1) in prostate cancer transcriptome | Q33212600 |
| | Delineation of TMPRSS2-ERG splice variants in prostate cancer | Q33357287 |
| | CFTR is a negative regulator of NFkappaB mediated innate immune response | Q33413105 |
| | MYC overexpression induces prostatic intraepithelial neoplasia and loss of Nkx3.1 in mouse luminal epithelial cells | Q33535955 |
| | Quantitative expression of TMPRSS2 transcript in prostate tumor cells reflects TMPRSS2-ERG fusion status. | Q33645816 |
| | Loss of Nkx3.1 expression in bacterial prostatitis: a potential link between inflammation and neoplasia | Q33816335 |
| | Prostate-localized and androgen-regulated expression of the membrane-bound serine protease TMPRSS2. | Q33873888 |
| | Antibody-based detection of ERG rearrangement-positive prostate cancer | Q34009867 |
| | Cooperativity of Nkx3.1 and Pten loss of function in a mouse model of prostate carcinogenesis. | Q34014956 |
| | NKX-3.1 interacts with prostate-derived Ets factor and regulates the activity of the PSA promoter. | Q34111030 |
| | Integrating differentiation and cancer: the Nkx3.1 homeobox gene in prostate organogenesis and carcinogenesis | Q34786771 |
| | Histone deacetylases are required for androgen receptor function in hormone-sensitive and castrate-resistant prostate cancer | Q35559975 |
| | Integration of regulatory networks by NKX3-1 promotes androgen-dependent prostate cancer survival | Q35665662 |
| | Nkx3.1 and Myc crossregulate shared target genes in mouse and human prostate tumorigenesis | Q35913655 |
| | Deciphering modular and dynamic behaviors of transcriptional networks | Q36513574 |
| | ETS rearrangements in prostate cancer | Q37047029 |
| | Recurrent gene fusions in prostate cancer | Q37194503 |
| | ETS family transcription factors collaborate with alternative signaling pathways to induce carcinoma from adult murine prostate cells | Q37257659 |
| | Transcription factors: from enhancer binding to developmental control | Q38032407 |
| | Recurrent gene fusions in prostate cancer: their clinical implications and uses | Q38102618 |
| | A hierarchical network of transcription factors governs androgen receptor-dependent prostate cancer growth | Q38299437 |
| | CHD1 is a 5q21 tumor suppressor required for ERG rearrangement in prostate cancer. | Q38317100 |
| | A mouse model of chronic prostatic inflammation using a human prostate cancer-derived isolate of Propionibacterium acnes. | Q38820147 |
| | Structural and functional interactions of the prostate cancer suppressor protein NKX3.1 with topoisomerase I. | Q39171279 |
| | Inflammation-mediated abrogation of androgen signaling: an in vitro model of prostate cell inflammation. | Q39293318 |
| | ERG oncogene modulates prostaglandin signaling in prostate cancer cells. | Q39616982 |
| | Coactivator selective regulation of androgen receptor activity | Q39848118 |
| | TWIST1, A novel androgen-regulated gene, is a target for NKX3-1 in prostate cancer cells | Q39858177 |
| | Androgen receptor controls EGFR and ERBB2 gene expression at different levels in prostate cancer cell lines | Q39868664 |
| | A role for DNA methylation in regulating the growth suppressor PMEPA1 gene in prostate cancer | Q40028399 |
| | Emergence of ETS transcription factors as diagnostic tools and therapeutic targets in prostate cancer | Q40028950 |
| | Detailed mapping of the ERG-ETS2 interval of human chromosome 21 and comparison with the region of conserved synteny on mouse chromosome 16. | Q40604496 |
| | ERG oncoprotein expression in prostate cancer: clonal progression of ERG-positive tumor cells and potential for ERG-based stratification | Q41489983 |
| | Cooperativity of TMPRSS2-ERG with PI3-kinase pathway activation in prostate oncogenesis | Q41778982 |
| | Nkx3.1; Pten mutant mice develop invasive prostate adenocarcinoma and lymph node metastases | Q44521056 |
| | NKX3.1 stabilizes p53, inhibits AKT activation, and blocks prostate cancer initiation caused by PTEN loss. | Q44590758 |
| | Androgen receptor binding sites identified by a GREF_GATA model | Q46742780 |
| | Expression of SLC26A3, CFTR and NHE3 in the human male reproductive tract: role in male subfertility caused by congenital chloride diarrhoea. | Q52568330 |
| | TMPRSS2-ERG fusion, a common genomic alteration in prostate cancer activates C-MYC and abrogates prostate epithelial differentiation. | Q54529505 |
| | The promoter connection | Q74592018 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | prostate cancer | Q181257 |
| P304 | page(s) | 16 | |
| P577 | publication date | 2014-01-13 | |
| P1433 | published in | BMC Cancer | Q326300 |
| P1476 | title | Loss of the NKX3.1 tumorsuppressor promotes the TMPRSS2-ERG fusion gene expression in prostate cancer | |
| P478 | volume | 14 | |